GHIT Fund Global Health Innovative Technology Fund

The GHIT Fund is an international organization that
supports product development of drugs, vaccines, and diagnostics
for malaria, tuberculosis and neglected tropical diseases (NTDs).

We fight neglected diseases through partnerships

Diseases "neglected" by the world

  • Malaria

    Deaths in 2023

    600,000＊

  • Tuberculosis

    Deaths in 2023

    1.25M＊

  • NTDs

    Cases in 2023

    1.5 B＊

Despite the many people suffering from various infectious diseases, such as malaria, tuberculosis, and neglected tropical diseases (NTDs), they have been “neglected" due to the lack of safe, approved products for treatment and prevention.

By comparison:
Deaths from lung
cancer in Japan

77,000＊

In 2022

Why developing new drugs for
neglected diseases is so difficult

  • This makes it difficult for companies to participate in product development

  • Patients are caught in a vicious cycle

Read more about challenges to development of new drugs
  • Our vision is a world free of neglected infectious diseases that affect over a billion people. Our aim: achieving health equity.
  • We leverage Japanese innovation and leadership to fight against neglected infectious diseases through investing in research and development and promoting global partnerships.

Our approach

The GHIT Fund is an international non-profit organization that supports product development of drugs, vaccines, and diagnostics for malaria, tuberculosis, and NTDs that are difficult for companies to invest in alone. We fundraise through global public-private partnerships.

  • Fundraising

  • Invest in R&D

  • Support delivery to patients

Read more about our Business Model Watch this video to learn about our Business Model

GHIT by the numbers

  • Total Investment
    Over USD350M＊＊
  • Total Invested Programs
    Over 130
  • Total Product
    Development Partners
    Over 180
  • Clinical Trials
    Approx. 10 projects
  • Registration
    1 project
Read more about our investment portfolio
As of March 31, 2025

Goals to be achieved by 2027

Delivering new drugs, vaccines, and diagnostics to patients who suffer
Read more about GHIT 3.0

Support from partners

It’s virtually impossible for a single company to develop a product alone.
The GHIT Fund is funded by the Government of Japan, United Nations Development Programme (UNDP), the pharmaceutical industry, the Bill & Melinda Gates Foundation, and Wellcome, as well as sponsors from a variety of private companies.

Tackling neglected infectious
diseases through global partnerships

The GHIT Fund serves as a networking hub to accelerate product development by connecting Japanese and global institutions, including governments, private companies, foundations, NGO/NPOs, and UN agencies.
  • Over60 Japanese
    organizations
  • Over120 non-Japanese
    organizations

Messages from partners & sponsors

Reference

Business Model
Annual Report 2024
Investment Overview